Yao-Chen Li
Overview
Explore the profile of Yao-Chen Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li R, Chen M, Liu J, Shao C, Guo C, Wei X, et al.
Cell Death Dis
. 2018 Dec;
9(12):1171.
PMID: 30518916
Recent studies indicate that the long noncoding RNA ATB (lncATB) can induce the epithelial-mesenchymal transition (EMT) in cancer cells, but the specific cellular targets of lncATB require further investigation. In...
2.
Lin H, Liang Y, Dou X, Chen C, Wei X, Zeng D, et al.
Oncogenesis
. 2018 Aug;
7(8):59.
PMID: 30100605
Notch3 and GATA binding protein 3 (GATA-3) have been, individually, shown to maintain luminal phenotype and inhibit epithelial-mesenchymal transition (EMT) in breast cancers. In the present study, we report that...
3.
Dou X, Liang Y, Lin H, Wei X, Zhang Y, Bai J, et al.
Theranostics
. 2017 Nov;
7(16):4041-4056.
PMID: 29109797
The luminal A phenotype is the most common breast cancer subtype and is characterized by estrogen receptor α expression (ERα). Identification of the key regulator that governs the luminal phenotype...
4.
Bai J, Zhang Y, Li Y, Zhang G
Methods Mol Biol
. 2017 Aug;
1652:259-274.
PMID: 28791647
Breast cancer, the most common malignancy among women worldwide, is a heterogeneous disease, and it therefore has remarkably different biological characteristics and clinical behavior. Breast cancer has been divided into...
5.
Liang Y, Zeng D, Xiao Y, Wu Y, Ouyang Y, Chen M, et al.
Cancer Lett
. 2016 Nov;
386:65-76.
PMID: 27838413
Tamoxifen resistance presents a prominent clinical challenge in endocrine therapy for hormone sensitive breast cancer. However, the underlying mechanisms that contribute to tamoxifen resistance are not fully understood. In this...
6.
Chen C, Dou X, Liang Y, Lin H, Bai J, Zhang X, et al.
Cell Cycle
. 2015 Dec;
15(3):432-40.
PMID: 26694515
Uncontrolled cell proliferation, genomic instability and cancer are closely related to the abnormal activation of the cell cycle. Therefore, blocking the cell cycle of cancer cells has become one of...
7.
Li Y, Zhu J
Appl Microbiol Biotechnol
. 2014 May;
98(17):7623-32.
PMID: 24846735
N-acyl homoserine lactone (AHL)-based quorum sensing (QS) has been recognized to play an important role in the formation of biofilm. However, aerobic granular sludge is considered as a special biofilm,...
8.
Li Y, Kong L, Li K
Ai Zheng
. 2006 May;
25(5):560-5.
PMID: 16687074
Background & Objective: Tumor necrosis factor alpha (TNF-alpha) is an important agent for tumor biotherapy because of its strong antitumor activity, but its clinical application is limited because of its...
9.
Li Y, Kong L, Cheng B, Li K
Avian Dis
. 2006 Jan;
49(4):562-73.
PMID: 16405000
Three plasmid constructs were prepared that express small interfering RNAs (siRNAs) targeted to sequences encoding the ribonucleoprotein member, nucleoprotein (NP) and/or PA, of influenza virus genome. The antiviral properties of...
10.
Li Y, Kong L, Wang Y, Shang N, Geng Y, Si L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
. 2004 May;
19(4):409-12.
PMID: 15163401
Aim: To purify preliminary recombinant human TNF-alpha mutein 471 and detect its bioactivity on the basis of the TNF-alpha mutein 471 expressed in prokaryotic express system. Methods: The expression of...